Approval · Notice of Compliance 2547 · 2001
ZANTAC: Notice of Compliance 2547
Issued July 19, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2547
- Date
- July 19, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Histamine H2-receptor antagonist
Products in this notice
Medicinal ingredients
- RANITIDINE HCL 15 MG per ML
- RANITIDINE HCL 300 MG per TAB
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 25 MG per ML